TrialBlood2021
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency.
Bryanna Reinhardt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled ittrialcites it